|
|
|
Volumn 6, Issue 2, 2008, Pages 91-93
|
|
New drugs for ovarian cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
5 AZA 2' DEOXYCYTIDINE;
BEVACIZUMAB;
BRCA1 PROTEIN;
BRCA2 PROTEIN;
CARBOPLATIN;
CYTOTOXIC AGENT;
DOXORUBICIN;
GEMCITABINE;
GROWTH FACTOR;
HEAT SHOCK PROTEIN 90;
MAMMALIAN TARGET OF RAPAMYCIN;
MONOCLONAL ANTIBODY;
NEW DRUG;
NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR;
PACLITAXEL;
PAZOPANIB;
PHOSPHATIDYLINOSITOL 3 KINASE;
PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR;
PLACEBO;
PLATINUM COMPLEX;
PROTEIN KINASE B;
PROTEIN KINASE B INHIBITOR;
PROTEIN MLH1;
PROTEIN TYROSINE KINASE INHIBITOR;
SORAFENIB;
TEMSIROLIMUS;
TOPOTECAN;
VASCULOTROPIN;
VASCULOTROPIN RECEPTOR;
ANTIANGIOGENIC ACTIVITY;
ANTINEOPLASTIC ACTIVITY;
APOPTOSIS;
ARTICLE;
CARCINOGENESIS;
CELL DAMAGE;
CLINICAL TRIAL;
CONTINUOUS INFUSION;
DRUG RECEPTOR BINDING;
DRUG TARGETING;
DRUG WITHDRAWAL;
HUMAN;
INTESTINE PERFORATION;
LOW DRUG DOSE;
MONOTHERAPY;
MULTIPLE CYCLE TREATMENT;
OVARY CANCER;
PROTEIN EXPRESSION;
PROTEIN SYNTHESIS INHIBITION;
SURVIVAL RATE;
UNSPECIFIED SIDE EFFECT;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BRCA2 PROTEIN;
CARBOPLATIN;
CLINICAL TRIALS, PHASE II AS TOPIC;
DRUG RESISTANCE, NEOPLASM;
FEMALE;
HUMANS;
OVARIAN NEOPLASMS;
PACLITAXEL;
PYRIMIDINES;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
SULFONAMIDES;
UBIQUITIN-PROTEIN LIGASES;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
|
|
EID: 41749087375
PISSN: 15430790
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (1)
|
|
References (5)
|
